Find clinical trials for Triple Negative Breast Cancer in Phoenix, AZ
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Triple Negative Breast Cancer trials near Phoenix, AZ, USA:
oral immuno-oncology product candidate targeting immune-suppressive tumor-associated myeloid cells through selective inhibition of phosphoin ...
Phase 2
Chandler, Arizona, United States and 23 other locations
or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after su...
Phase 3
Phoenix, Arizona, United States and 165 other locations
the RP2D. The RP2D will be administered to 3 cohorts of patients in the Dose Expansion Phase.* Cohort A: Advanced or Metastatic Triple Negative...
Phase 1, Phase 2
Phoenix, Arizona, United States and 15 other locations
CAR T-cell therapy, in patients with ROR1+ relapsed or refractory triple negative breast cancer (TNBC), non-small...
Phase 1
Scottsdale, Arizona, United States and 17 other locations
to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received n...
Phase 3
Chandler, Arizona, United States and 104 other locations
vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).After a screening ph...
Phase 3
Scottsdale, Arizona, United States and 192 other locations
with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...
Phase 3
Tempe, Arizona, United States and 360 other locations
or metastatic (spread to other parts of the body); triple negative breast cancer; epithelial ovarian cancer...
Phase 2
Scottsdale, Arizona, United States and 55 other locations
monotherapy versus olaparib in combination with an inhibitor of WEE1 (adavosertib \[AZD1775\]) in second or third line setting in patients with Triple...
Phase 2
Gilbert, Arizona, United States and 140 other locations
and antitumor activity of PRO1107 in patients with advanced solid tumors. This study consists of 2 parts, Part A: dose escalation and dose l...
Phase 1, Phase 2
Scottsdale, Arizona, United States and 3 other locations
Clinical trials
Research sites
Resources
Legal